Brendan Fox
Marc Zabeau

Brendan Fox, Ph.D.

Brendan Fox was President and CEO of Elanco Animal Health, a division of Eli Lilly & Company, from 1990 to 2001. Dr. Fox worked in research, regulatory affairs, marketing, and line management in both the United States and Europe, becoming executive director of Elanco's International Animal Health Business in 1987. Upon his appointment as President of Elanco in 1990, Dr. Fox became a member of Lilly's Senior Management group.

Prior to Elanco, Dr. Fox had a broad range of international experience in animal health with Burroughs Wellcome and Shell International Chemical Company, London, working in Europe, Latin America, and Africa. Dr. Fox was an active participant for many years in Animal Health Industry Association affairs in both Europe and the United States and is a past President of COMISA, the forerunner of IFAH, the worldwide industry association for animal health. Dr. Fox served as CEO and a Board member of Pyxis Genomics, a leading animal genomics company and is an Advisor to the recently announced Mid-Point Food and Ag Fund which is aimed at developing start up companies bringing new technologies to the AgBio field .

He graduated from University of Edinburgh in Veterinary Medicine and Surgery in 1967 and is a member of the Royal College of Veterinary Surgeons.



Proud Member of the National Venture Capital Association & The Global Agtech Investors Network

Copyright 2010 Cultivian Ventures | All rights reserved.